“Clinical testing has been one of the biggest barriers to developing new imaging technology for clinical application”, says Alvira Macanovic, IP, Regulatory and Clinical Affairs Manager at the Centre for Imaging Technology Commercialization (CIMTEC). “This very important CIMTEC initiative will make it easier for researchers and small and medium-sized companies to achieve a range of goals such as generating clinical data to support pre-market regulatory submissions, or to demonstrate clinical utility for driving adoption and reimbursement.”
The Centre for Imaging Technology Commercialization (CIMTEC) is expanding its capabilities today by launching its Clinical Testing Services. CIMTEC’s newest service offering provides customized planning, management, and monitoring support for its customers from engaging key opinion leaders, developing protocols and study materials, to closeout.
Dr. Lionel Lenkinski, President & CEO of 3D Imaging Partners says, “CIMTEC got us thinking about issues that are critical to the success of medical devices, such as the accuracy and the workflow involved in the clinical use of our software. We were looking for outside validation and we couldn’t have found a better partner for clinical testing.”
CIMTEC has a complete suite of services to manage an entire clinical study, or individual services to augment the resources of its customers. Their experience allows them to manage clinical studies in a wide range of clinical areas such as radiology, interventional radiology, neurology, oncology, cardiovascular, ophthalmology, and musculo-skeletal.
CIMTEC is strengthening its position in the industry as a one-stop-shop for medical imaging technology commercialization by developing services that span the entire commercialization continuum. From business development through technology development and clinical testing, any researcher or company involved in the process of bringing their medical imaging innovation to market will benefit from CIMTEC’s extensive knowledge and industry experience.
